Literature DB >> 9694056

Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias.

R M Pereira1, E R Velloso, Y Menezes, S Gualandro, J Vassalo, N H Yoshinari.   

Abstract

We studied 21 bone marrow specimens from 21 patients with systemic lupus erythematosus (SLE) and peripheral cytopenias: anaemia (Hb < 10 g/dl), and/or leucopenia (white blood cell count < 4 x 10(9)/l), and/or thrombocytopenia (platelets < 150 x 10(9)/l). None of the patients had used immunosuppressive drugs in the 2 months before the study, and 11 (52.4%) had never used these drugs. The global and specific series cellularity, degree of fibrosis and necrosis were evaluated by bone marrow trephine; morphological abnormalities and iron stores were evaluated by cytological smears. The most important abnormalities viewed in bone marrow biopsies were: global hypocellularity (47.6%), increased reticulin proliferation (76.2%) with myelofibrosis in one patient, and necrosis (19.0%). The marrow aspirates were difficult to obtain in four patients, who showed an increased reticulin proliferation on histological analysis. Plasmocytosis was present in 26.7% of cases and in one there was a serum monoclonal component (IgG kappa). Iron stores were normal or increased in 26.7% of specimens and decreased or absent in 73.3%. The most frequent peripheral abnormality was leucopenia in 90.4% (19/21) and granulocytic hypoplasia was observed in 47.3% (9/19) of these patients. We conclude that the bone marrow may be a target organ in SLE with cytopenias.

Entities:  

Mesh:

Year:  1998        PMID: 9694056     DOI: 10.1007/bf01451051

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  THE BONE MARROW IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  R BURKHARDT
Journal:  Semin Hematol       Date:  1965-01       Impact factor: 3.851

2.  The lupus activity criteria count (LACC).

Authors:  M B Urowitz; D D Gladman; E C Tozman; C H Goldsmith
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

3.  Plasmapheresis in active systemic lupus erythematosus: effects on clinical, serum, and cellular abnormalities. Case report.

Authors:  N I Abdou; H B Lindsley; A Pollock; D J Stechschulte; G Wood
Journal:  Clin Immunol Immunopathol       Date:  1981-04

4.  Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients.

Authors:  R B Stricker; M A Shuman
Journal:  Am J Hematol       Date:  1984-08       Impact factor: 10.047

5.  Immunologic abnormalities in myelofibrosis with activation of the complement system.

Authors:  B R Gordon; M Coleman; P Kohen; N K Day
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

6.  Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus.

Authors:  H M Daly; G L Scott
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

7.  Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.

Authors:  M J Walport; W N Hubbard; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

8.  Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?

Authors:  C Roffe; M R Cahill; A Samanta; S Bricknell; S T Durrant
Journal:  Br J Rheumatol       Date:  1991-08

9.  Systemic lupus erythematosus and myelofibrosis.

Authors:  W G Kaelin; J L Spivak
Journal:  Am J Med       Date:  1986-11       Impact factor: 4.965

10.  Neutropenia associated with myelofibrosis in systemic lupus erythematosus.

Authors:  E F Borba; R M Pereira; E D Velloso; I A Pereira; C R Goncalves; N H Yoshinari
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

View more
  19 in total

1.  Suspects in the tale of lupus-associated thrombocytopenia.

Authors:  P D Ziakas; J G Routsias; S Giannouli; A Tasidou; A G Tzioufas; M Voulgarelis
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus.

Authors:  Alastair L Hepburn; Irvin A Lampert; Joseph J Boyle; Donna Horncastle; W Fai Ng; Mark Layton; Timothy J Vyse; Marina Botto; Justin C Mason
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

Review 4.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

5.  Dramatic development of severe SLE in a patient with an incomplete disease.

Authors:  G Fabio; M Carrabba; C Hu; M Floriani; C Besana
Journal:  Rheumatol Int       Date:  2005-01-21       Impact factor: 2.631

6.  Aplastic anemia associated to systemic lupus erythematosus in an AIDS patient: a case report.

Authors:  Leonardo Rodrigues de Oliveira; Thaís Camargos Ferreira; Fernando de Freitas Neves; Antônio Carlos de Oliveira Meneses
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 7.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 8.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

9.  Visceral leishmaniasis resembling systemic lupus erythematosus.

Authors:  Michalis Voulgarelis; Paraskevi V Voulgari; John Serelis; Alexandros A Drosos; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2003-10-31       Impact factor: 2.980

10.  Autoimmune Myelofibrosis in Systemic Lupus Erythematosus Report of Two Cases and Review of the Literature.

Authors:  Prasad R Koduri; Mohammad Parvez; Sashidhar Kaza; S Vanajakshi
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-15       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.